Yeast Infection
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis (NCT03167957) | Matinas BioPharma Nanotechnologies, Inc. | 2019-12-01 |
| Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) (NCT02971007) | Matinas BioPharma Nanotechnologies, Inc. | 2016-11-01 |
| Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization (NCT02888197) | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2016-08-16 |
| RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections (NCT02733432) | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2016-06-08 |
Track Yeast Infection automatically
Every clearance here is in the API, with alerts when new ones post.